Amira Modi Becomes COO and Board Member At Sygnature Discovery

Amira joins Sygnature Discovery and brings a wealth of experience from the life sciences industry, having held leadership positions at IQVIA and GSK. Most recently, she served as the Global Head of Go-to-Market Technology Solutions at IQVIA, where she successfully led the integration of acquisitions and drove the development of new products for the market.

Amira expressed her excitement about her appointment saying, “I am delighted to join Sygnature Discovery at this pivotal time to build on its successes to date and drive the next phase of growth. I was attracted to the role by both its reputation for scientific excellence and its ability to provide high quality and tailored services to clients. I look forward to utilizing my experience in transforming and leading diverse teams to drive Sygnature’s vision of becoming the leading global drug discovery CRO.”

In her new role at Sygnature Discovery, Amira will be essential in shaping and executing the company’s strategic objectives. She’ll oversee group operations and lead the North American business, focusing on improving efficiency and implementing changes that will help build a sustainable and scalable company.

With her extensive background in the life sciences sector, along with her experience in scaling businesses and managing mergers and acquisitions, Amira is set to play a key role in enhancing Sygnature’s data capabilities. This will be crucial as the company continues to grow and adapt to new challenges.

Dr Simon Hirst, CEO of Sygnature Discovery, commented, “We are thrilled to welcome Amira to Sygnature Discovery. Her leadership and vision will undoubtedly make a significant impact as we continue to push the boundaries of innovation in drug discovery. Amira’s strategic insight and proven ability to lead transformative initiatives have consistently driven growth in global organizations. The Board believes that her alignment with Sygnature Discovery’s commitment to excellence, collaboration, and innovation makes her an ideal fit for this role. Her track record of leading high-performing teams and crafting innovative go-to-market strategies is poised to further strengthen our company.”